INNOVAX - ILT-SB

Poultry

Therapeutic Class

Sub-species

Diseases

Innovax®-ILT-SB



Fowl Laryngotracheitis-Marek’s Disease Vaccine
(Serotypes 2 + 3, Modified Live and Live Marek’s Disease Vector)

For vaccination of 18-day-old embryos to aid in the prevention of Infectious Laryngotracheitis and very virulent Marek’s disease.

Advantages:
One single injection of Innovax-ILT-SB by the in ovo route:

  • Provides extended protection against both ILTV and very virulent MD.

  • Eliminates respiratory vaccination reactions caused by chickens vaccinated with live conventional ILT vaccines.

  • Eliminates an increase in the vaccination reactions from other respiratory vaccines.

  • Eliminates latency, persistence and spread caused by chickens vaccinated with live conventional ILT vaccines.

  • Prevents vaccine induced ILT outbreaks.

Description 
Innovax-ILT-SB  vaccine is a frozen, live, cell-associated Laryngotracheitis and Marek’s disease (MD) vaccine. It provides proven protection against Infectious Laryngotracheitis (ILT) and very virulent MD. It is approved for in ovo injection of 18-day embryonated eggs.

Innovax-ILT-SB contains a turkey herpes virus (HVT) used as a vector for the expression of the glycoprotein genes from Laryngotracheitis virus. The HVT is combined with the SB-1 strain of chicken herpes virus (serotype 2).

Supplied in 2,000 dose ampules.

Indications for use

Dosage and Administration
The vaccine should be thawed immediately before use. Care should be taken to mix all of the vaccine from the ampule into the diluent for maximum efficacy. Once mixed with diluent, the vaccine should be swirled frequently, every five minutes, to maintain uniform distribution. In ovo vaccination of 18-day embryonated eggs should follow the instructions provided by the In ovo equipment manufacturer.

Innovax-ILT-SB is indicated for the vaccination of 18-day-old embryos by the In ovo route as an aid in the prevention of Infectious Laryngotracheitis and very virulent Marek’s disease.

Vaccination
The best protection is obtained when the vaccinated chickens have time to develop immunity before exposure to Infectious Laryngotracheitis and Marek’s disease viruses. Good management canister in liquid nitrogen container, expose only the ampule to be used immediately. We recommend handling only one ampule at a time. After removing the ampule from the cane, the remaining ampules should be replaced immediately in the canister of the liquid nitrogen container.

Cautions

1. Refer to package insert for specific directions.

2. Vaccine should be stored in liquid nitrogen at a temperature below -150°C.

3. Gloves and visor should be worn when handling liquid nitrogen.

4. Once thawed, the product should not be refrozen.

5. Do not dilute the vaccine or otherwise stretch the dosage of the vaccine.

6. Once mixed with diluent, the vaccine should be used within one hour, and unused vaccine should be discarded into disinfectant or burned.

7. Vaccinate only healthy chickens. Do not vaccinate chickens within 21 days of slaughter.

8. Do not mix this vaccine with any other substances.

9. Vaccination equipment must be cleaned and sterilized before use.

10. This product is not hazardous when used according to directions supplied. A material safety data sheet (MSDS) is available upon request.

Contact our sales or technical services representatives to help design a custom vaccination program.

Website
www.innovaxvaccines.com

Product Label(s) and MSDS